ALL
Pharma in China
Pharma Experts
Market News
Products Guide
Brand Story
-
Tremfya Approved by FDA as Selective Interleukin (IL)-23 Inhibitor for Psoriatic Arthritis
July 22, 2020The Janssen Pharmaceutical Companies of Johnson & Johnson announced the U.S. Food and Drug Administration (FDA) has approved TREMFYA® (guselkumab) for adult patients with active psoriatic arthritis (PsA), a chronic progressive disease characterized by ...
Pharma Sources Insight January 2025
